Our first press release is out!
Many exciting things are on the horizon for this September that we would like to share with everyone in the drug repurposing community!
REPO4EU - the Euro-Global platform for Mechanism-based Drug Repurposing is officially kicking off next month and with it also comes to life RExPO22 - the first international conference on drug repurposing.
You can read all about it in our first joint press release!
Photo by Utsav Srestha on Unsplash
A new piece on Alzheimer from our colleagues at STALICLA
Our colleague Emre Guney from STALICLA (a member of REPO4EU) is one of the co-authors of “A needle for Alzheimer’s in a haystack of claims data“.
In the era of big data, looking for insights in large datasets has become the norm — and health data are no exception. Combining systems-biology-driven, endophenotype-based analysis of drug targets with large-scale medical claims data points to sildenafil as a potential treatment opportunity for Alzheimer’s disease
Photo by David Matos on Unsplash
Sounds interesting?
Make sure to check out the full article in the link below
Network medicine for disease module identification and drug repurposing with the NeDRex platform
A new paper has been published recently under the title of Network medicine for disease module identification and drug repurposing with the NeDRex platform.
Sounds interesting?
You can navigate to the full text via the link below
Network pharmacology: curing causal mechanisms instead of treating symptoms
A new paper has been published recently under the title of Network pharmacology: curing causal mechanisms instead of treating symptoms.
Photo by Roberto Sorin on Unsplash
Sounds interesting?
Make sure to check out the full article in the link below